Goldman Sachs analyst Jamie Perse downgraded HCA Healthcare to Neutral from Buy with a $271 price target. The firm’s rating change is “largely a relative call” versus peer stocks in the hospital space where it sees more meaningful catalysts over the next 12 months and greater multiple expansion upside potential, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HCA:
- HCA Healthcare price target lowered to $290 from $310 at Argus
- Early notable gainers among liquid option names on November 17th
- HCA Healthcare price target lowered to $265 from $313 at JPMorgan
- Third Point buys T-Mobile, boosts Microsoft in Q3
- HCA Healthcare provides five-year targets ahead of investor day
